Home Contact us Site Map
 
 
 
News
  
1
July, 2008: Finasteride Registered in KSA Market

TPMC has successfully registered a branded generic “Finasteride” in the...

   more
    -------------------------------------------
July, 2008: Tabuk Diversifies its Products Portfolio in Turkey

After the successful launch of Tabuk’s first product Brospect® to the hospital...

   more
    -------------------------------------------
July, 2008: Tabuk Receives Registration Approvals for Three Products in France

Tabuk is currently operating through local partners in France, and has managed...

   more
    -------------------------------------------
July, 2008: Twenty Six (26) New Products Added to Tabuk’s Portfolio in the MENA Region

Being one of the top local pharmaceutical manufacturing companies in the region, and as part of...

   more
    -------------------------------------------
June, 2008: Tabuk & Panpharma Sign an Exclusive Agreement

Tabuk announced today that it had signed an exclusive agreement with...

   more
    -------------------------------------------
June, 2008: TPMC Sponsors Saudi Cardiologists to the International Society of Hypertension

As part of Lorvast’s ® “Atorvastatin” launching campaign in Saudi, Tabuk...

 

   more
    -------------------------------------------
June, 2008: Tabuk Managed to Register Two Products in Different Therapeutic Categories in the Very Competitive Market of Poland

Registration approvals of Simvastatin & Betahistine in the cholesterol lowering agents and...

   more
    -------------------------------------------
June, 2008: Tabuk had Received Registration Approvals for Two Products in Hungary

As part of its growth strategy in the Easter European Market, Tabuk had received registration approvals...

 

   more
    -------------------------------------------
May, 2008: Launching “Candeur®” in KSA

Tabuk has launched Candeur®; an antifungal prescription...

 

   more
    -------------------------------------------
May, 2008: Launching of Lotense® in Lebanon

Lotense® “Amlodipine besylate 5mg capsules” has been successfully launched in...

   more
    -------------------------------------------
May, 2008: Launching of Zinoximor® 500 mg in Jordan

Zinoximor® is Cefuroxime Axetil 500 mg F.C Tab. it is an oral second generation...

   more
    -------------------------------------------
May, 2008: Meiact® Launching symposia in Kuwait, Jordan and Libya with the attendance of the international speakers; Mr. Ko Kishimoto and Mr. Tanaka –from Meiji- Japan

Meiact® is a new under licensed molecule from Meiji- Japan, Cefditoren Pivoxil 400mg F.C. Tab., It is an...

   more
    -------------------------------------------
April, 2008: Launching of Toprazole® in Jordan

Jordan's pharmaceutical market is growing and Tabuk, being one of the...

   more
    -------------------------------------------
April, 2008: Launching of Winex® 400 mg in UAE and Qatar

As part of Tabuk’s growth strategy in the gulf region, Tabuk has...

   more
    -------------------------------------------
April, 2008: TPMC Guarantees First-to-Market Blockbuster Product

TPMC guarantees a First-to-Market blockbuster product; Clopidogrel, as it was the first and only...

   more
    -------------------------------------------
March, 2008: Launching Lorvast® ‘Atorvastatin” and Protec® “Cefepime” in KSA

Three successful symposia were conducted for the launch of Lorvast® “Atorvastatin” in the...

   more
    -------------------------------------------
March, 2008: Enforcing the company position in Libya

Tabuk introduced 15 products and built up a sizable competitive...

   more
    -------------------------------------------
January, 2008: TPMC Successfully Launched Two OTC Products in KSA

TPMC had successfully launched two OTC products in KSA; Prokinin® ”Domperidone” & Ezipan® “Hedra Helix & Thymus Vulgare”...

   more
    -------------------------------------------
January, 2008: Tabuk Continues its Expansion in the Turkish Market

A second injectable product (Rekson®) was launched in January, 2008. Rekson® Set (Ceftriaxone Na in IV form) is the first...

   more
    -------------------------------------------
TPMC Established its Regional Office in Cairo

In March 2007, Tabuk Pharmaceutical Manufacturing Company established its Regional Office...

 

   more
    -------------------------------------------
Tabuk pharmaceutical launched “FACTIVE” in Saudi Arabia

In May 2007 Tabuk pharmaceutical launched “FACTIVE” in Saudi Arabia and soon will be launched in the rest of the Gulf region.  Factive is an under licensed products from LG Korea, the product is a new generation...

   more
    -------------------------------------------

[ Home | Query Form | Site Map ]

Copy right reserved to TABUK Pharmaceutical Mfg  CO.
Designed & Powered by eSolutions